EUVIMEDSkopri EUVIMED
Open access

Immunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease

David E Kleiner, Mauricio Lisker-Melman, Abdus S Wahed, Atul K Bhan, Michael A Nalesnik, Eun-Young K Choi, Kelsey K Leonard, Marc G Ghany, Raymond T Chung, Adrian M Di Bisceglie iD, Hepatitis B Research Network

Journal of Gastroenterology and Hepatology · 2023

DOI: 10.1111/jgh.16167 ↗

At a glance

Journal article in Journal of Gastroenterology and Hepatology, 2023. Written by David E Kleiner and 10 co-authors. Institution: Laboratory of Pathology, National Institutes of Health, Bethesda, Maryland, USA. Major MEDLINE topics: Hepatitis B, Chronic, Hepatitis B. Cited 4 times so far (Crossref); 24 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NCATS NIH HHS, NCRR NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and Aim Staining for hepatitis B viral antigens is often done in liver biopsies from patients with chronic hepatitis B, but its correlates with clinical phenotypes are not well described.

Methods

Biopsies were collected from a large cohort of adults and children with chronic hepatitis B viral infection through the Hepatitis B Research Network. Immunohistochemical staining of sections was done for hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg) and then centrally read by the pathology committee. The degree of liver injury and pattern of staining were then correlated with clinical characteristics, including the clinical phenotype of hepatitis B.

Results

Biopsies from 467 subjects were studied, including 46 from children. Immunostaining for HBsAg was positive in 417 (90%) with scattered hepatocyte staining being the most common pattern. HBsAg staining correlated best with serum levels of HBsAg and hepatitis B viral DNA; the absence of HBsAg staining was often a prelude to loss of HBsAg from serum. HBcAg staining was positive in 225 (49%), and, while cytoplasmic staining was more frequent than nuclear staining, both nuclear and cytoplasmic positivity were often seen in the same specimen. Staining for HBcAg correlated with both level of viremia and liver injury. No biopsies from inactive carriers had stainable HBcAg, while 91% of the biopsies from those with hepatitis B e antigen‐positive chronic hepatitis B stained positively for HBcAg.

Conclusion

Immunostaining for hepatitis B viral antigens may yield helpful insights into liver disease pathogenesis but appears to add little to commonly used serological and biochemical blood tests.

Subjects

MeSH terms (MEDLINE)

Hepatitis B, ChronicHepatitis BHumansHepatitis B Surface AntigensHepatitis B Core AntigensLiverHepatitis B virusDNA, Viral

Author keywords

hepatitis B, clinicalhepatologyhepatology, hepatitis B, immunologyhepatology, hepatitis B, virology

Substances

Hepatitis B Surface AntigensHepatitis B Core AntigensDNA, Viral

Authors and institutions

  • Laboratory of Pathology, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Department of Statistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA.
  • Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Pathology, University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, USA.
  • Department of Pathology, University of Michigan - Michigan Medicine, Ann Arbor, Michigan, USA.

ORCID profiles: Adrian M Di Bisceglie

Funding

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NCRR NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Center for Advancing Translational Sciences
  • Gilead Sciences

Cite

APA

Kleiner, D. E., Lisker-Melman, M., Wahed, A. S., Bhan, A. K., Nalesnik, M. A., Choi, E. K., Leonard, K. K., Ghany, M. G., Chung, R. T., Di Bisceglie, A. M., & Hepatitis B Research Network (2023). Immunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16167

Vancouver

Kleiner DE, Lisker-Melman M, Wahed AS, Bhan AK, Nalesnik MA, Choi EK, et al. Immunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease. Journal of Gastroenterology and Hepatology. 2023. doi:10.1111/jgh.16167

BibTeX
@article{Kleiner2023,
  author = {Kleiner, David E and Lisker-Melman, Mauricio and Wahed, Abdus S and Bhan, Atul K and Nalesnik, Michael A and Choi, Eun-Young K and Leonard, Kelsey K and Ghany, Marc G and Chung, Raymond T and Di Bisceglie, Adrian M and Hepatitis B Research Network, Hepatitis B Research Network},
  title = {Immunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2023},
  doi = {10.1111/jgh.16167}
}
Start for free →